These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

638 related articles for article (PubMed ID: 32839951)

  • 1. Neurological manifestations of COVID-19: available evidences and a new paradigm.
    Khatoon F; Prasad K; Kumar V
    J Neurovirol; 2020 Oct; 26(5):619-630. PubMed ID: 32839951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ageusia and anosmia, a common sign of COVID-19? A case series from four countries.
    Vargas-Gandica J; Winter D; Schnippe R; Rodriguez-Morales AG; Mondragon J; Escalera-Antezana JP; Trelles-Thorne MDP; Bonilla-Aldana DK; Rodriguez-Morales AJ; Paniz-Mondolfi A
    J Neurovirol; 2020 Oct; 26(5):785-789. PubMed ID: 32666422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurological injuries in COVID-19 patients: direct viral invasion or a bystander injury after infection of epithelial/endothelial cells.
    Azizi SA; Azizi SA
    J Neurovirol; 2020 Oct; 26(5):631-641. PubMed ID: 32876900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The neurological manifestations of COVID-19: a review article.
    Niazkar HR; Zibaee B; Nasimi A; Bahri N
    Neurol Sci; 2020 Jul; 41(7):1667-1671. PubMed ID: 32483687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COVID-19 and the nervous system.
    Berger JR
    J Neurovirol; 2020 Apr; 26(2):143-148. PubMed ID: 32447630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spectrum of Neurological Manifestations in Covid-19: A Review.
    Garg RK
    Neurol India; 2020; 68(3):560-572. PubMed ID: 32643664
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinvasion, neurotropic, and neuroinflammatory events of SARS-CoV-2: understanding the neurological manifestations in COVID-19 patients.
    Yachou Y; El Idrissi A; Belapasov V; Ait Benali S
    Neurol Sci; 2020 Oct; 41(10):2657-2669. PubMed ID: 32725449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurological manifestations in coronavirus disease 2019.
    Corona T; Rodríguez-Violante M; Delgado-García G
    Gac Med Mex; 2020; 156(4):317-320. PubMed ID: 32831319
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe rapidly progressive Guillain-Barré syndrome in the setting of acute COVID-19 disease.
    Abrams RMC; Kim BD; Markantone DM; Reilly K; Paniz-Mondolfi AE; Gitman MR; Choo SY; Tse W; Robinson-Papp J
    J Neurovirol; 2020 Oct; 26(5):797-799. PubMed ID: 32720233
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurology of COVID-19 revisited: A proposal from the Environmental Neurology Specialty Group of the World Federation of Neurology to implement international neurological registries.
    Román GC; Spencer PS; Reis J; Buguet A; Faris MEA; Katrak SM; Láinez M; Medina MT; Meshram C; Mizusawa H; Öztürk S; Wasay M;
    J Neurol Sci; 2020 Jul; 414():116884. PubMed ID: 32464367
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the neurotropic characteristics of SARS-CoV-2: from neurological manifestations of COVID-19 to potential neurotropic mechanisms.
    Zhou Z; Kang H; Li S; Zhao X
    J Neurol; 2020 Aug; 267(8):2179-2184. PubMed ID: 32458193
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurological Sequelae of COVID-19.
    Ahmad SJ; Feigen CM; Vazquez JP; Kobets AJ; Altschul DJ
    J Integr Neurosci; 2022 Apr; 21(3):77. PubMed ID: 35633158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurological manifestations of COVID-19.
    Kanwar D; Baig AM; Wasay M
    J Pak Med Assoc; 2020 May; 70(Suppl 3)(5):S101-S103. PubMed ID: 32515379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Facial diplegia, a possible atypical variant of Guillain-Barré Syndrome as a rare neurological complication of SARS-CoV-2.
    Juliao Caamaño DS; Alonso Beato R
    J Clin Neurosci; 2020 Jul; 77():230-232. PubMed ID: 32410788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of the Nervous System in SARS-CoV-2 Infection.
    Li H; Xue Q; Xu X
    Neurotox Res; 2020 Jun; 38(1):1-7. PubMed ID: 32399719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic.
    COVID-19 Host Genetics Initiative
    Eur J Hum Genet; 2020 Jun; 28(6):715-718. PubMed ID: 32404885
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19-Associated Encephalitis Mimicking Glial Tumor.
    Efe IE; Aydin OU; Alabulut A; Celik O; Aydin K
    World Neurosurg; 2020 Aug; 140():46-48. PubMed ID: 32479911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurological complications of coronavirus and COVID-19.
    Carod-Artal FJ
    Rev Neurol; 2020 May; 70(9):311-322. PubMed ID: 32329044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Guillain-Barre syndrome during COVID-19 pandemic: an overview of the reports.
    Rahimi K
    Neurol Sci; 2020 Nov; 41(11):3149-3156. PubMed ID: 32876777
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Global Initiative Seeks to Crack the COVID-19 Genetic Code.
    Am J Med Genet A; 2020 Sep; 182(9):1998-1999. PubMed ID: 32881367
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 32.